Literature DB >> 24761016

Application of genomic principles to pharmacotherapy of cancer.

Christopher L Farrell1, Nancy G Pedigo1, Amy R Messersmith1.   

Abstract

OBJECTIVES: To teach first-year (P1) pharmacy students to apply the principles of pharmacogenomics underlying clinical pharmacotherapeutics to cancer patients.
DESIGN: Using polymerase chain reaction (PCR) and high-resolution melting analysis of deoxyribonucleic acid (DNA) from colorectal cancer cell lines to determine the presence of somatic mutations for an oncogenic marker, students formulated the proper course of treatment for a patient with similar tumor genomics. ASSESSMENT: In a postintervention survey, students highly rated the effectiveness of the laboratory session for learning pharmacogenomics, and subsequent examination scores reflected retention of principles and understanding of clinical application.
CONCLUSION: The pharmacogenomic laboratory exercise prepared students to understand how genetic markers give clinical insight into the appropriate application of drugs in oncology pharmacotherapy. Further, the session inspired their interest in learning more about pharmacogenomics and their professional roles in personalized medicine.

Entities:  

Keywords:  active learning; cancer; genomics; oncology; pharmacogenomics; pharmacotherapy

Mesh:

Substances:

Year:  2014        PMID: 24761016      PMCID: PMC3996387          DOI: 10.5688/ajpe78355

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  35 in total

1.  Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E.

Authors:  Anne Jarry; Damien Masson; Elisabeth Cassagnau; Sigrid Parois; Christian Laboisse; Marc G Denis
Journal:  Mol Cell Probes       Date:  2004-10       Impact factor: 2.365

2.  Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Authors:  Paul T C Wan; Mathew J Garnett; S Mark Roe; Sharlene Lee; Dan Niculescu-Duvaz; Valerie M Good; C Michael Jones; Christopher J Marshall; Caroline J Springer; David Barford; Richard Marais
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

3.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line.

Authors:  B Drewinko; M M Romsdahl; L Y Yang; M J Ahearn; J M Trujillo
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

4.  Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.

Authors:  Hong Yang; Brian Higgins; Kenneth Kolinsky; Kathryn Packman; William D Bradley; Richard J Lee; Kathleen Schostack; Mary Ellen Simcox; Scott Kopetz; David Heimbrook; Brian Lestini; Gideon Bollag; Fei Su
Journal:  Cancer Res       Date:  2011-12-16       Impact factor: 12.701

5.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

6.  Human colonic adenocarcinoma cells. I. Establishment and description of a new line.

Authors:  B H Tom; L P Rutzky; M M Jakstys; R Oyasu; C I Kaye; B D Kahan
Journal:  In Vitro       Date:  1976-03

Review 7.  Therapeutic potential of ABX-EGF: a fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment.

Authors:  David H Lynch; Xiao-Dong Yang
Journal:  Semin Oncol       Date:  2002-02       Impact factor: 4.929

8.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Authors:  David Cunningham; Yves Humblet; Salvatore Siena; David Khayat; Harry Bleiberg; Armando Santoro; Danny Bets; Matthias Mueser; Andreas Harstrick; Chris Verslype; Ian Chau; Eric Van Cutsem
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.

Authors:  Scott M Wilhelm; Christopher Carter; Liya Tang; Dean Wilkie; Angela McNabola; Hong Rong; Charles Chen; Xiaomei Zhang; Patrick Vincent; Mark McHugh; Yichen Cao; Jaleel Shujath; Susan Gawlak; Deepa Eveleigh; Bruce Rowley; Li Liu; Lila Adnane; Mark Lynch; Daniel Auclair; Ian Taylor; Rich Gedrich; Andrei Voznesensky; Bernd Riedl; Leonard E Post; Gideon Bollag; Pamela A Trail
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 13.312

View more
  6 in total

1.  Pharmacogenomics Education Improves Pharmacy Student Perceptions of Their Abilities and Roles in Its Use.

Authors:  Rebecca Marcinak; Meaghan Paris; Shannon R M Kinney
Journal:  Am J Pharm Educ       Date:  2018-11       Impact factor: 2.047

2.  An Effective Approach to Teaching Pharmacogenomics in the First Year of Pharmacy Curriculum.

Authors:  Marina Gálvez-Peralta; Grazyna D Szklarz; Werner J Geldenhuys; Paul R Lockman
Journal:  Am J Pharm Educ       Date:  2018-10       Impact factor: 2.047

Review 3.  Educational strategies to enable expansion of pharmacogenomics-based care.

Authors:  Kristin Wiisanen Weitzel; Christina L Aquilante; Samuel Johnson; David F Kisor; Philip E Empey
Journal:  Am J Health Syst Pharm       Date:  2016-12-01       Impact factor: 2.637

Review 4.  Emerging roles for pharmacists in clinical implementation of pharmacogenomics.

Authors:  Aniwaa Owusu-Obeng; Kristin W Weitzel; Randy C Hatton; Benjamin J Staley; Jennifer Ashton; Rhonda M Cooper-Dehoff; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2014-09-15       Impact factor: 4.705

Review 5.  Improving medical students' knowledge of genetic disease: a review of current and emerging pedagogical practices.

Authors:  Michael J Wolyniak; Lynne T Bemis; Amy J Prunuske
Journal:  Adv Med Educ Pract       Date:  2015-10-29

6.  Pharmacogenomics: From classroom to practice.

Authors:  Samantha C Nutter; Marina Gálvez-Peralta
Journal:  Mol Genet Genomic Med       Date:  2018-05-31       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.